Approval Of Nonprescription Plan B Sales To Women Over Age 18 "Not Enough" To Reduce Need For Abortion Opinion Piece Says
FDA's decision to approve Barr Laboratories' application for nonprescription sales of its emergency contraceptive Plan B to women ages 18 and older is "welcome news" but it will not be "enough to overcome our nation's stalled progress in reducing unintended pregnancies and the need for abortion" [click link for full article]
0 Comments:
Post a Comment
<< Home